Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwMyeloma 2022 | Unmet needs and challenges in amyloidosis

Angela Dispenzieri • 27 Mar 2022
iwMyeloma 2022
Amyloidosis

Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN, discusses unmet needs in amyloidosis, drawing focus on the importance of raising awareness and improving therapeutic options for patients. Dr Dispenzieri also highlights challenges in this field, including the need to improve the definition for progression-free survival (PFS) and supportive care for patients. This interview took place at The International Workshop on Myeloma 2022, held in Scottsdale, AZ.

More from Angela Dispenzieri

1:53
Unmet needs in amyloidosis: early diagnosis, treating relapsed disease & progression criteria
Angela Dispenzieri • 6 Sep 2023
2:30
Emerging AL amyloidosis treatments: immunotherapies & targeting amyloid plaque deposits
Angela Dispenzieri • 6 Sep 2023
1:42
The current SOC in AL amyloidosis: dara-CyBorD & considerations for patients with relapsed disease
Angela Dispenzieri • 6 Sep 2023
1:57
Rationale behind the watch and wait strategy in smoldering myeloma
Angela Dispenzieri • 6 Sep 2023

Related Videos

1:55
Safety and efficacy of NXC-201, an anti-BCMA CAR-T, in R/R AL amyloidosis
Vaishali Sanchorawala • 11 Dec 2023
1:55
Quantifying biomarkers on lambda amyloidogenic light chains to diagnose AL amyloidosis
Vaishali Sanchorawala • 11 Dec 2023
3:14
The impact of amyloid deposits in AL amyloidosis
Paolo Milani • 22 Nov 2023
1:58
Safety of birtamimab in AL amyloidosis: pooled analysis from multiple studies
Vaishali Sanchorawala • 12 Dec 2023
The content of VJHemOnc is intended for healthcare professionals